Literature DB >> 10092143

Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan.

F Tsuda1, H Okamoto, M Ukita, T Tanaka, Y Akahane, K Konishi, H Yoshizawa, Y Miyakawa, M Mayumi.   

Abstract

Recently, a nonenveloped single-stranded DNA virus named TT virus (TTV) has been reported in association with non-A to G post-transfusion as well as sporadic acute and chronic liver disease. A method was developed for the detection of antibody to TTV (anti-TTV) by means of immune precipitation and detection of TTV DNA by the polymerase chain reaction. The test serum was incubated with TTV, recovered from feces of a carrier, and after incubation, the formed immune complexes were precipitated with goat antiserum to human IgG. TTV DNA was sought for by the polymerase chain reaction in both precipitate and supernatant. The detection of TTV DNA in the precipitate, but not in the supernatant, was considered to represent anti-TTV in the test serum. Of the 44 healthy blood donors in Japan, anti-TTV was detected in one of the six (17%) with TTV DNA and 11 of the 38 (29%) without TTV DNA. In the two patients with post-transfusion non-A to G hepatitis, free anti-TTV developed as they cleared TTV in serum. Anti-TTV complexed with TTV in serum, detectable by precipitating sera with goat anti-human IgG and testing for TTV DNA, elicited while the patients had elevated alanine transaminase levels. The determination of anti-TTV would be useful for detecting resolved infection in surveys for exposure to TTV in the general population, and for establishing the mechanism of liver injury associated with TTV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092143     DOI: 10.1016/s0166-0934(98)00154-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Sequestration of TT virus of restricted genotypes in peripheral blood mononuclear cells.

Authors:  H Okamoto; M Takahashi; N Kato; M Fukuda; A Tawara; S Fukuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Sequence heterogeneity of TT virus and closely related viruses.

Authors:  Y E Khudyakov; M E Cong; B Nichols; D Reed; X G Dou; S O Viazov; J Chang; M W Fried; I Williams; W Bower; S Lambert; M Purdy; M Roggendorf; H A Fields
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Species-specific TT viruses and cross-species infection in nonhuman primates.

Authors:  H Okamoto; M Fukuda; A Tawara; T Nishizawa; Y Itoh; I Hayasaka; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 4.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 5.  TT virus as a human pathogen: significance and problems.

Authors:  C Springfeld; J J Bugert; P Schnitzler; E Tobiasch; R Kehm; G Darai
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

6.  Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection.

Authors:  T Nishizawa; H Okamoto; F Tsuda; T Aikawa; Y Sugai; K Konishi; Y Akahane; M Ukita; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

7.  Development of a Serological Assay for the Sea Lion (Zalophus californianus) Anellovirus, ZcAV.

Authors:  Elizabeth Fahsbender; Karyna Rosario; John P Cannon; Frances Gulland; Larry J Dishaw; Mya Breitbart
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

Review 8.  Torque teno virus in liver diseases: On the way towards unity of view.

Authors:  Vasiliy I Reshetnyak; Igor V Maev; Alexandr I Burmistrov; Igor A Chekmazov; Tatiana I Karlovich
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.